In the eyes, it can lead to retinopathy, optic nerve damage, and glaucoma by reducing blood flow and triggering inflammation
Here are the average weight loss results based on the dose and timeline: 1 mg: 7.2% in 24 weeks and 8.7% in 48 weeks 4 mg: 12.9% in 24 weeks and 16.3% in 48 weeks 8 mg: 17.3% in 24 weeks and 23.9% in 48 weeks 12 mg: 17.5% in 24 weeks and 24.2% in 48 weeks Placebo: 1.6% in 24 weeks and 2.1% in 48 weeks The retatrutide clinical trials are still ongoing, with a phase IV planned after the current phase III
NAC has established medical uses, including treatment of acetaminophen toxicity and use as a mucolytic medication
Statistical analysis of animal survival was performed using a log-rank (MantelCox) test
are completely ignored due to lack of knowledge
The main objective of this narrative review was to examine the potential benefits, dosages, and mechanisms of GLP-1 receptor agonists on alcohol consumption and how they can potentially modify alcohol-seeking behavior